Therefore, downregulation of ERα and/or PR signaling or selection of ERα-negative SSM2 tumor cells is not the main mechanism used by SSM2 cells to survive in the absence of ovarian hormones in the bone microenvironment. The gene discussed is ESR1; the disease is neoplasm.